Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer. (Q53470792)
Jump to navigation
Jump to search
scientific article published in August 2007
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer. |
scientific article published in August 2007 |
Statements
Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer. (English)
W Kimryn Rathmell
Jared A Gollob
Tina M Richmond
Christine B Marino
Elizabeth K Miller
Gayle Grigson
Catharine Watkins
Lin Gu
Bercedis L Peterson
John J Wright
1 August 2007
25
22
3288-3295